Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients
The Delta variant of SARS-CoV-2 has caused many breakthrough infections in fully vaccinated individuals. While vaccine status did not generally impact the number of viral RNA genome copies in nasopharyngeal swabs of breakthrough patients, as measured by Ct values, it has been previously found to decrease the infectious viral load in symptomatic patients. We quantified the viral RNA, infectious virus, and anti-spike IgA in nasopharyngeal swabs collected from individuals asymptomatically infected with the Delta variant of SARS-CoV-2. Vaccination decreased the infectious viral load, but not the amount of viral RNA. Furthermore, vaccinees with asymptomatic infections had significantly higher levels of anti-spike IgA in their nasal secretions compared to unvaccinated individuals with asymptomatic infections. Thus, vaccination may decrease the transmission risk of Delta, and perhaps other variants, despite not affecting the amount of viral RNA measured in nasopharyngeal swabs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Viruses - 14(2022), 9 vom: 18. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Plante, Jessica A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
B.1.617.2 |
|---|
| Anmerkungen: |
Date Completed 26.09.2022 Date Revised 07.02.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/v14092071 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34663248X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34663248X | ||
| 003 | DE-627 | ||
| 005 | 20231226031922.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/v14092071 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1155.xml |
| 035 | |a (DE-627)NLM34663248X | ||
| 035 | |a (NLM)36146877 | ||
| 035 | |a (PII)2071 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Plante, Jessica A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.09.2022 | ||
| 500 | |a Date Revised 07.02.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The Delta variant of SARS-CoV-2 has caused many breakthrough infections in fully vaccinated individuals. While vaccine status did not generally impact the number of viral RNA genome copies in nasopharyngeal swabs of breakthrough patients, as measured by Ct values, it has been previously found to decrease the infectious viral load in symptomatic patients. We quantified the viral RNA, infectious virus, and anti-spike IgA in nasopharyngeal swabs collected from individuals asymptomatically infected with the Delta variant of SARS-CoV-2. Vaccination decreased the infectious viral load, but not the amount of viral RNA. Furthermore, vaccinees with asymptomatic infections had significantly higher levels of anti-spike IgA in their nasal secretions compared to unvaccinated individuals with asymptomatic infections. Thus, vaccination may decrease the transmission risk of Delta, and perhaps other variants, despite not affecting the amount of viral RNA measured in nasopharyngeal swabs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a B.1.617.2 | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a IgA | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a breakthrough | |
| 650 | 4 | |a delta | |
| 650 | 4 | |a vaccination | |
| 650 | 7 | |a Immunoglobulin A |2 NLM | |
| 650 | 7 | |a RNA, Viral |2 NLM | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 700 | 1 | |a Machado, Rafael R G |e verfasserin |4 aut | |
| 700 | 1 | |a Mitchell, Brooke M |e verfasserin |4 aut | |
| 700 | 1 | |a Shinde, Divya P |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Jordyn |e verfasserin |4 aut | |
| 700 | 1 | |a Scharton, Dionna |e verfasserin |4 aut | |
| 700 | 1 | |a McConnell, Allan |e verfasserin |4 aut | |
| 700 | 1 | |a Saada, Nehad |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Jianying |e verfasserin |4 aut | |
| 700 | 1 | |a Khan, Bilal |e verfasserin |4 aut | |
| 700 | 1 | |a Campos, Rafael K |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Bryan A |e verfasserin |4 aut | |
| 700 | 1 | |a Menachery, Vineet D |e verfasserin |4 aut | |
| 700 | 1 | |a Levine, Corri B |e verfasserin |4 aut | |
| 700 | 1 | |a Ren, Ping |e verfasserin |4 aut | |
| 700 | 1 | |a McLellan, Susan L F |e verfasserin |4 aut | |
| 700 | 1 | |a Plante, Kenneth S |e verfasserin |4 aut | |
| 700 | 1 | |a Weaver, Scott C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Viruses |d 2009 |g 14(2022), 9 vom: 18. Sept. |w (DE-627)NLM192382764 |x 1999-4915 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:9 |g day:18 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/v14092071 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2022 |e 9 |b 18 |c 09 | ||